Nanox (NASDAQ: NNOX) has entered into a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The announcement, made on September 11, 2026, marks Nanox's third Latin American market this year, following agreements in Argentina and Peru.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This partnership positions Nanox to penetrate Costa Rica's public healthcare system through a well-established local distributor.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the broader Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
Nanox is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. Nanox's vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.
For investors, this agreement signals continued execution of Nanox's global expansion strategy. The company's shares trade on the Nasdaq under the ticker NNOX. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. To view the full press release, visit https://ibn.fm/C77lJ.
This expansion into Costa Rica is significant because it demonstrates Nanox's ability to secure partnerships with distributors that have established relationships with national healthcare providers. By targeting the CCSS, Nanox gains access to a centralized purchaser that can facilitate widespread adoption of its technology. The initial proof-of-concept registration period will allow Nanox and SOLME to demonstrate the Nanox.ARC's value in a real-world setting, potentially leading to full registration and broader deployment. If successful, this model could be replicated in other markets, accelerating Nanox's mission to make medical imaging more accessible and affordable worldwide. For patients in Costa Rica, the introduction of advanced 3D imaging could lead to earlier detection of diseases and improved clinical outcomes, aligning with Nanox's goal of advancing preventive care.
As with any forward-looking statements, there are risks and uncertainties that could cause actual results to differ materially from expectations. These include regulatory delays, market acceptance, and other factors beyond management's control. Nonetheless, the agreement represents a concrete step in Nanox's strategy to expand its footprint in Latin America and beyond.
